Deutsche Bank’s Edwards Lifesciences EW Stock Holding History

Deutsche Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-324	Closed	-$19K	–	5215
2018 Q3	$19K	Buy	+324	New	+$15.8K	﹤0.01%	4942
2018 Q1	–	Sell	-750	Closed	-$28K	–	5460
2017 Q4	$28K	Buy	+750	New	+$27.5K	﹤0.01%	4591
2015 Q1	–	Sell	-7,044	Closed	-$149K	–	5334
2014 Q4	$149K	Hold	7,044	–	–	﹤0.01%	4458
2014 Q3	$119K	Hold	7,044	–	–	﹤0.01%	4397
2014 Q2	$100K	Sell	7,044 -2,652	-27%	-$36K	﹤0.01%	4568
2014 Q1	$21K	Hold	9,696	–	–	﹤0.01%	4822
2013 Q4	$12K	Buy	+9,696	New	+$109K	﹤0.01%	4850

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Deutsche Bank's EW Position: Q1 2026 in Review

Deutsche Bank increased its Edwards Lifesciences (EW) stake by 8.5% in Q1 2026, buying an estimated $39.3M and bringing the position to 6,055,023 shares worth $485M. The position accounts for 0.16% of the portfolio, ranked #136.

Deutsche Bank first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $511M in Q4 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Deutsche Bank held 6,055,023 shares of Edwards Lifesciences worth $485M as of Q1 2026.
Deutsche Bank bought 476,227 Edwards Lifesciences shares in Q1 2026, an estimated $39.3M.
Edwards Lifesciences made up 0.16% of Deutsche Bank's portfolio in Q1 2026, its #136 holding.
Deutsche Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
Deutsche Bank's Edwards Lifesciences position peaked at $511M in Q4 2024.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.